
BTCS Inc. ETH and Cash Market Value Now $242 Million
$189 million raised year-to-date through hallmark DeFi/TradFi Accretion Flywheel strategy
SILVER SPRING, MD, July 21, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq:
BTCS
) ('BTCS' or the 'Company'), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that the combined market value of its 55,788 ETH holdings, cash1, and other liquid holdings are approximately $242.2 million, based on an ETH price of $3,600. Additionally, the Company has agreed to issue $10 million in convertible notes through its previously established $56 million arrangement with ATW Partners LLC.
While the funding is extremely modest relative to the $189 million raised year-to-date, the nearly 200% conversion premium is consistent with, and further demonstrates, BTCS's execution of its hallmark DeFi/TradFi Accretion Flywheel strategy. The Company limited this financing to $10 million as part of its strategy to maintain financial flexibility for opportunistic future leverage while maintaining its loan-to-value ratio below 40%. This approach aligns with BTCS's commitment to maximizing ETH exposure and minimizing shareholder dilution.
DeFi/TradFi Accretion Flywheel Update
BTCS is successfully executing its DeFi/TradFi Accretion Flywheel capital formation strategy, leveraging both decentralized and traditional finance to expand its ETH holdings, capitalize on its vertically integrated operations, and enhance shareholder value. The Company has raised capital through a mix of at-the-market equity sales, above-market convertible debt, and DeFi-based borrowing, executed in alignment with its strategy to optimize ETH exposure while actively managing dilution, as detailed below.
Year-to-Date Funding Summary
ATM Sales: $132 million1 (70%)
Above-Market Convertible Debt: $17 million (9%)
Aave Stablecoin Loans (DeFi): $40 million (21%)
Total year-to-date funding: $189 million
Total Crypto & Cash Assets: $242 million1
ETH Holdings: 55,788 (average cost per ETH: $2,846), a 516% year-to-date increase
'
We believe that BTCS is the most financially and operationally leveraged Ethereum play in public markets today,
' said Charles Allen, CEO of BTCS. '
Our vertically integrated block-building and node operations are generating record revenue, and when combined with solid execution of our hallmark DeFi/TradFi Accretion Flywheel, BTCS offers investors scalable, high-growth exposure to Ethereum.
'
________________________________
1 Inclusive of $28.4 million ATM sales at $7.9 per share pending settlement and funds from the pending closing of the $10 million convertible note.
Above Market Convertible Note Financing
The $10 million principal amount notes are convertible into common stock at a fixed conversion price of $13 per share, representing a 198% premium over the Company's $6.57 closing stock price on Friday, July 18, 2025. The notes have a two-year maturity, expiring on July 21, 2027, include a 5% original issue discount, and bear interest at an annual rate of 6%.
In connection with the note issuance, five-year warrants will be issued at closing to purchase 879,375 shares of common stock at an exercise price of $8 per share, representing a 122% premium to the closing price on Friday, July 18, 2025. The funding is expected to close on or before Tuesday, July 22, 2025.
Notably, the financing involves no investment banking fees or restrictive terms typically associated with using an investment bank or placement agent, which could hinder the execution of the Company's DeFi/TradFi Accretion Flywheel strategy.
As part of the financing terms, the Company agreed that, while the notes remain outstanding, it will not amend its non-convertible Series V Preferred Shares to allow for conversion into common stock for a period of 18 months.
Capital Structure Update
To help investors accurately assess BTCS's intrinsic value and compare it with its peers, we're providing an updated breakdown of our capital structure. This summary provides additional information to supplement our SEC filings.
Approximately 16 million shares of Series V are now excluded from the fully diluted share count, as they are non-convertible and, under the terms of the note financing, cannot be amended to be convertible for 18 months.
In light of the restriction and given the new administration's growing acceptance of crypto and the broader recognition that real-world assets will be tokenized, the Company may re-explore various options to create liquidity for the Series V preferred shares, including potential tokenization on Ethereum's blockchain. However, it is still very early, and the Company can provide no guarantees or assurances that it will be able to tokenize or create liquidity for the Series V and may ultimately seek to convert the Series V to common stock when the restriction expires. As such, the Series V has been excluded from the table above.
About BTCS:
BTCS Inc. ('BTCS' or the 'Company'), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ('DeFi') and traditional finance ('TradFi') mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at
www.btcs.com
.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this press release constitute 'forward-looking statements' within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 including statements regarding creating high growth exposure to Ethereum, creating liquidity for Series V, and closing of the $10 million note offering. Words such as 'may,' 'might,' 'will,' 'should,' 'believe,' 'expect,' 'anticipate,' 'estimate,' 'continue,' 'predict,' 'forecast,' 'project,' 'plan,' 'intend' or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon assumptions and are subject to various risks and uncertainties, including without limitation market conditions, regulatory issues and requirements, unanticipated issues with our At-The-Market Offering facility, unexpected issues with Builder+, as well as risks set forth in the Company's filings with the Securities and Exchange Commission including its Form 10-K for the year ended December 31, 2024 which was filed on March 20, 2025. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements, whether as a result of new information, future events or otherwise, except as required by law.
For more information follow us on:
Twitter:
https://x.com/NasdaqBTCS
LinkedIn:
https://www.linkedin.com/company/nasdaq-btcs
Facebook:
https://www.facebook.com/NasdaqBTCS
Investor Relations:
Charles Allen –
CEO
X (formerly Twitter):
@Charles_BTCS
Email:
ir@btcs.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d2a20376-f8bd-4008-9c82-cdb4bc63b69e
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Entegris (ENTG) Nosedives 14.46% on Dismal Earnings
We recently published . Entegris, Inc. (NASDAQ:ENTG) is one of the worst-performing stocks on Tuesday. Entegris nosedived by 14.46 percent on Wednesday to close at $79.34 apiece as investors soured on its dismal earnings performance and shunned a highly confident outlook for the current quarter of the year. In its updated report, Entegris, Inc. (NASDAQ:ENTG) said that net income dropped by 22 percent in the second quarter of the year to $52.8 million from $67.7 million in the same period last year. Net sales also dipped by 2.5 percent to $792.4 million from $812.7 million year-on-year. Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place Machine. Computer Chip Manufacturing at Fab. Semiconductor Packaging Process. 'Semiconductor industry trends are largely unchanged. AI-enabled applications are driving significant growth in advanced logic and HBM. However, elsewhere, fab activity remains subdued. And in the short term, the uncertainty around trade policies and the macroeconomic environment will continue to have an impact on semiconductor demand,' said Entegris, Inc. (NASDAQ:ENTG) President and CEO Bertrand Loy. Despite the disappointing figures, Loy said that the company is highly optimistic about its business outlook for the rest of the year. 'Looking further ahead, nothing has changed in our long-term view of the industry. We remain very optimistic and continue to have high confidence in the strong long-term growth outlook for the market and Entegris,' he noted. While we acknowledge the potential of ENTG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
5 minutes ago
- Yahoo
META: Meta Shares Soar After Doubling 2025 AI Investment
July 31 - Meta (NASDAQ:META) shares surged 10% in pre-market trading Thursday after the company revealed plans to double its artificial intelligence investment in 2025 to as much as $72 billion. The aggressive spending aims to expand data centers, servers, and recruit AI talent, signaling Meta's determination to dominate next?gen computing. Warning! GuruFocus has detected 5 Warning Sign with META. The company highlighted two major AI infrastructure projects. Prometheus, in Ohio, is expected to reach 1 gigawatt of computing power by 2026, while Hyperion in Louisiana could eventually scale to 5 gigawatts. These energy?intensive plans have sparked environmental concerns, including local reports of water shortages tied to existing facilities in Georgia. Meta posted $47.5 billion in second?quarter revenue, driven by AI?powered advertising tools that enhance translations and video generation. It forecasts Q3 revenue between $47.5 billion and $50.5 billion, even as its Reality Labs unit reported a $4.5 billion loss. Capital spending is set to rise again in 2026 as Meta continues to pursue personal superintelligence and evaluates selective co?financing deals for new data centers. The massive AI commitment positions the social media giant at the center of the U.S. AI infrastructure race. Is META a Buy Now? Based on the one year price targets offered by 61 analysts, the average target price for Meta Platforms Inc is $748.94 with a high estimate of $935.00 and a low estimate of $566.00. The average target implies a upside of +7.73% from the current price of $695.21. Based on GuruFocus estimates, the estimated GF Value for Meta Platforms Inc in one year is $544.27, suggesting a downside of -21.71% from the current price of $695.21. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus.
Yahoo
5 minutes ago
- Yahoo
Should You be Confident in Argenx SE (ARGX)?
Baron Funds, an investment management company, released its 'Baron Health Care Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care Index (benchmark) and a 10.99% gain for the Russell 3000 Index (the Index). In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Argenx SE (NASDAQ:ARGX). Argenx SE (NASDAQ:ARGX) designs and manufactures electrical, electronic, and fiber optic connectors. The one-month return of Argenx SE (NASDAQ:ARGX) was 10.20%, and its shares gained 16.02% of their value over the last 52 weeks. On July 30, 2025, Argenx SE (NASDAQ:ARGX) stock closed at $598.89 per share, with a market capitalization of $36.652 billion. Baron Health Care Fund stated the following regarding Argenx SE (NASDAQ:ARGX) in its second quarter 2025 investor letter: "Argenx SE (NASDAQ:ARGX is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. Shares declined after Q1 Vyvgart sales came in below elevated investor expectations due to a combination of seasonal factors (such as insurance reverification) and higher Medicare Part D utilization and associated discounts. Our conversations with management and neurologists continue to reinforce Vyvgart's value as an important treatment option with strong long-term growth potential. The drug continues to launch well in both generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Over time, we expect Vyvgart to demonstrate efficacy across an expanding range of autoantibody-driven autoimmune conditions, supported by encouraging Phase 2 myositis data recently presented by argenx at a major medical conference." A lab setting filled with scientific equipment and researchers in lab coats working together to develop new therapies for autoimmune diseases. Argenx SE (NASDAQ:ARGX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 54 hedge fund portfolios held Argenx SE (NASDAQ:ARGX) at the end of the first quarter, which was 47 in the previous quarter. While we acknowledge the potential of Argenx SE (NASDAQ:ARGX) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Argenx SE (NASDAQ:ARGX) and shared the list of high growth stocks outside tech analysts are bullish on. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data